Influence of Genetic Variations on Ovarian Cancer and p53 Expression
Author Information
Author(s): P Sarhanis, C Redman, C Perrett, K Brannigan, RN Clayton, P Hand, C Musgrove, V Suarez, P Jones, AA Fryer, WE Farrell, RC Strange
Primary Institution: University of Keele, North Staffordshire Hospital
Hypothesis
The study investigates the influence of polymorphisms at the GSTM1, GSTT1, and CYP2D6 loci on the expression of p53 in epithelial ovarian cancer.
Conclusion
The study found that the GSTM1 null genotype is significantly associated with p53 overexpression in ovarian cancer patients.
Supporting Evidence
- 20 out of 23 p53-positive patients were found to have the GSTM1 null genotype.
- The frequency of GSTT1 null approached significance in p53-positive cases.
- Patients with both GSTM1 null and GSTT1 null genotypes were more common in the immunopositive group.
Takeaway
Some people have genes that don't work well to clean up harmful stuff in their bodies, which can lead to cancer. This study found that one of those genes is linked to a protein that helps control cell growth.
Methodology
The study used a case-control design, comparing genotype frequencies and p53 expression in ovarian cancer patients and controls, utilizing immunohistochemistry and DNA sequencing.
Limitations
The study may not account for all genetic factors influencing ovarian cancer risk and p53 expression.
Participant Demographics
Patients were 84 unrelated, northern European Caucasian women with a median age of 59 years.
Statistical Information
P-Value
0.002
Statistical Significance
p=0.002
Want to read the original?
Access the complete publication on the publisher's website